These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 15597632

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. USDA licensing policy for biologicals produced by R-DNA.
    Espeseth DA, Shibley GP, Joseph PL, van Deusen RA, Whetstone CA.
    Dev Biol Stand; 1985; 59():167-73. PubMed ID: 4007275
    [Abstract] [Full Text] [Related]

  • 7. History of regulatory requirements for poultry biologics in the United States, 1970s to 1990s.
    Espeseth DA, Lasher H.
    Avian Dis; 2013 Jun; 57(2):167-71. PubMed ID: 24689169
    [Abstract] [Full Text] [Related]

  • 8. The Unites States Department of Agriculture Regulation of Veterinary Biological Products. The use of prelicensing evaluation and postlicensing monitoring to achieve regulatory compliance.
    Hill RE, Randall DC.
    Qual Assur; 1995 Dec; 4(4):323-8. PubMed ID: 8890360
    [Abstract] [Full Text] [Related]

  • 9. Regulation of veterinary biological products for fish in the United States.
    Birnbaum NG.
    Dev Biol Stand; 1997 Dec; 90():335-40. PubMed ID: 9270861
    [Abstract] [Full Text] [Related]

  • 10. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA.
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [Abstract] [Full Text] [Related]

  • 11. Alternative Methods to Reduce, Refine, and Replace the Use of Animals In the Development and Testing of Veterinary Biologics in The United States; a Strategic Priority.
    Hill RE.
    Procedia Vaccinol; 2011 Oct; 5():141-145. PubMed ID: 32288916
    [Abstract] [Full Text] [Related]

  • 12. Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license--FDA. Proposed rule.
    Fed Regist; 1998 Jul 31; 63(147):40858-71. PubMed ID: 10181717
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Canadian regulatory requirements for recombinant fish vaccines.
    Sethi MS, Gifford GA, Samagh BS.
    Dev Biol Stand; 1997 Jul 31; 90():347-53. PubMed ID: 9270863
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Translating research into licensed vaccines and validated and licensed diagnostic tests.
    Hill RE, Foley PL, Clough NE, Ludemann LR, Murtle DC.
    Dev Biol (Basel); 2013 Jul 31; 135():53-8. PubMed ID: 23689883
    [Abstract] [Full Text] [Related]

  • 19. The American manufacturer's view on the EEC texts and harmonization.
    Draayer HA, Hilsabeck LJ, Miller RH.
    Dev Biol Stand; 1992 Jul 31; 79():77-83. PubMed ID: 1286768
    [Abstract] [Full Text] [Related]

  • 20. License requirements for recombinant DNA veterinary biologics in U.S.A.
    La Salle B.
    Dev Biol Stand; 1985 Jul 31; 59():181-4. PubMed ID: 4007277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.